Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7717)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2023 (publication date) through Apr 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luo M, Xin RJ, Hu FR, Yao L, Hu SJ, Bai FH. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis. World J Gastroenterol 2023; 29(1): 144-156 [PMID: 36683714 DOI: 10.3748/wjg.v29.i1.144] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v29/i1/144.htm |
| Number | Citing Articles |
| 1 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Ekaterina Vasilieva, Yury Zharikov, Andrey Suslov, Yana Letyagina, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Epidemiology of small intestinal bacterial overgrowth. World Journal of Gastroenterology 2023; 29(22): 3400-3421 doi: 10.3748/wjg.v29.i22.3400
Abstract(1120) |
Core Tip(730) |
Full Article(HTML)(21620)
|
Full Article with Cover (PDF)-1256K(209)
|
Full Article (Word)-195K(41)
|
Audio-930K(12)
|
Peer-Review Report-241K(94)
|
Answering Reviewers-118K(102)
|
Full Article (PDF)-605K(992)
|
Full Article (XML)-330K(107)
|
Times Cited (38)
|
Total Visits (27455)
|
Open
|
| 2 |
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Sergio Castorina, Stefano Puleo, Martina Barchitta, Antonella Agodi, Luisa Gallo, Gaetano La Greca, Saverio Latteri. Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database. Biology 2023; 12(5): 662 doi: 10.3390/biology12050662
|
| 3 |
Ke Yang, Guangqin Li, Qihong Li, Wei Wang, Xu Zhao, Nan Shao, Hui Qiu, Jing Liu, Lin Xu, Juanjuan Zhao. Distribution of gut microbiota across intestinal segments and their impact on human physiological and pathological processes. Cell & Bioscience 2025; 15(1) doi: 10.1186/s13578-025-01385-y
|
| 4 |
Jia-Lin Wu, Jun-Wei Chen, Ming-Sheng Huang, Xin-Yi Deng, Jia-Jun Deng, Tsz Yu Lau, Shi-Yu Cao, Hui-Ying Ran, Zai-Bo Jiang, Jun-Yang Luo. The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis. BMC Medical Genomics 2024; 17(1) doi: 10.1186/s12920-024-01939-y
|
| 5 |
Aysun Yakut. Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway. World Journal of Gastroenterology 2024; 30(43): 4672-4676 doi: 10.3748/wjg.v30.i43.4672
|
| 6 |
Loredana Vesci, Giulia Martinelli, Yongqiang Liu, Luca Tagliavento, Mario Dell’Agli, Yunfei Wu, Sara Soldi, Valeria Sagheddu, Stefano Piazza, Enrico Sangiovanni, Francesco Meneguzzo. The New Phytocomplex AL0042 Extracted from Red Orange By-Products Inhibits the Minimal Hepatic Encephalopathy in Mice Induced by Thioacetamide. Biomedicines 2025; 13(3): 686 doi: 10.3390/biomedicines13030686
|
| 7 |
Aysun Yakut. Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis. World Journal of Hepatology 2025; 17(3): 104167 doi: 10.4254/wjh.v17.i3.104167
|
| 8 |
Anne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Anthony H V Schapira, Rajeshwar P Mookerjee, Karen Louise Thomsen. The liver–brain axis in metabolic dysfunction-associated steatotic liver disease. The Lancet Gastroenterology & Hepatology 2025; 10(3): 248 doi: 10.1016/S2468-1253(24)00320-0
|
| 9 |
Erliang Li, Wenjing Niu, Chao Lu, Min Wang, Xin Xu, Ke Xu, Peng Xu. Interoception and aging. Ageing Research Reviews 2025; 108: 102743 doi: 10.1016/j.arr.2025.102743
|
| 10 |
莎 王. Study on the Influence of Intestinal Flora on the Pathogenesis and Treatment Strategy of Related Complications of Liver Cirrhosis. Advances in Clinical Medicine 2025; 15(04): 2009 doi: 10.12677/acm.2025.1541148
|
| 11 |
Weiguang Zou, Jiawei Hong, Wenchao Yu, Yaobin Ma, Jiacheng Gan, Yanbo Liu, Xuan Luo, Weiwei You, Caihuan Ke. Comprehensive Comparison of Effects of Antioxidant (Astaxanthin) Supplementation from Different Sources in Haliotis discus hannai Diet. Antioxidants 2023; 12(8): 1641 doi: 10.3390/antiox12081641
|
| 12 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Maria Zharkova, Oxana Zolnikova, Gyunay Bagieva, Vladimir Ivashkin. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis. World Journal of Hepatology 2024; 16(5): 822-831 doi: 10.4254/wjh.v16.i5.822
Abstract(398) |
Core Tip(380) |
Full Article(HTML)(1259)
|
Full Article with Cover (PDF)-3851K(75)
|
Audio-711K(38)
|
Peer-Review Report-226K(65)
|
Answering Reviewers-34K(49)
|
Supplementary Material-129K(54)
|
Full Article (PDF)-857K(97)
|
Full Article (XML)-134K(51)
|
Times Cited (1)
|
Total Visits (3974)
|
Open
|
| 13 |
Chao Ju, Longtao Yang, Xuemei Wang, Yisong Wang, Shixiong Tang, Jun Liu. Minimal hepatic encephalopathy: a bibliometric analysis (1999–2023). Current Psychology 2025; doi: 10.1007/s12144-025-07495-7
|
| 14 |
Xinxin Yu, Shihao Wang, Zhongjie Ji, Jiaqi Meng, Yunying Mou, Xinyi Wu, Xu Yang, Panyang Xiong, Mingxia Li, Yinghui Guo. Ferroptosis: An important mechanism of disease mediated by the gut-liver-brain axis. Life Sciences 2024; 347: 122650 doi: 10.1016/j.lfs.2024.122650
|
| 15 |
Adrian Martyniak, Magdalena Wójcicka, Iwona Rogatko, Tomasz Piskorz, Przemysław J. Tomasik. A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth. Microorganisms 2025; 13(1): 57 doi: 10.3390/microorganisms13010057
|
| 16 |
Natalia A. Osna, Larisa Y. Poluektova, Kusum K. Kharbanda. Neuroimmune Pharmacology and Therapeutics. 2024; : 299 doi: 10.1007/978-3-031-68237-7_18
|
| 17 |
Juan-José Gallego, María-Pilar Ballester, Alessandra Fiorillo, Franc Casanova-Ferrer, Adrià López-Gramaje, Amparo Urios, Yaiza María Arenas, María-Pilar Ríos, Lucía Durbán, Javier Megías, Teresa San-Miguel, Salvador Benlloch, Paloma Lluch, Rajiv Jalan, Carmina Montoliu. Ammonia and beyond – biomarkers of hepatic encephalopathy. Metabolic Brain Disease 2025; 40(1) doi: 10.1007/s11011-024-01512-7
|
| 18 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis. International Journal of Molecular Sciences 2024; 25(4): 1988 doi: 10.3390/ijms25041988
|
| 19 |
Kyung-Joo Kim, Hyoleem Lee, Yoon Sin Oh, Se-Eun Jang. Weissella koreensis KJ, Which Increases Gut Tight Junction Protein Expression, Alleviates TNBS-Induced Colitis by Suppressing Inflammatory Cytokines. Microbiology Research 2024; 15(2): 721 doi: 10.3390/microbiolres15020047
|
| 20 |
Arghya Samanta, Moinak Sen Sarma. Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective. World Journal of Hepatology 2024; 16(5): 678-683 doi: 10.4254/wjh.v16.i5.678
|
| 21 |
Ali Sepehrinezhad, Ali Shahbazi. Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management. 2024; doi: 10.5772/intechopen.1004125
|
| 22 |
Xiao Tong, Hussain Hussain, Nagarajarao Shamaladevi, Michael Norenberg, Aya Fadel, Omar El Hiba, El Abdeljalil, Bilal El-Mansoury, Deepak Kempuraj, Sampath Natarajan, Andrew Schally, Miklos Jaszberenyi, Luis Salgueiro, Michael Paidas, Arumugam Jayakumar. Age and Sex in the Development of Hepatic Encephalopathy: Role of Alcohol. Biology 2024; 13(4): 228 doi: 10.3390/biology13040228
|
| 23 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 2024; 6(1): 64 doi: 10.3390/gidisord6010005
|
| 24 |
D. Yu. Konstantinov, L. L. Popova, S. Yu. Vasilev, M. A. Popilov. Clinical experience of using Polysorb in complex pathogenetic therapy of chronic hepatitis C with severe liver fibrosis. Meditsinskiy sovet = Medical Council 2024; (8): 82 doi: 10.21518/ms2024-191
|
| 25 |
Ali Sepehrinezhad, Ali Shahbazi. Experimental and Clinical Methods in Hepatic Encephalopathy Research. Neuromethods 2025; 219: 259 doi: 10.1007/978-1-0716-4354-9_11
|
| 26 |
Jakub Rochoń, Piotr Kalinowski, Ksenia Szymanek-Majchrzak, Michał Grąt. Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(23): 2964-2980 doi: 10.3748/wjg.v30.i23.2964
|